|
|
News Breaks
|
December 13, 2011
|
| 09:46 EDT |  | AFFX, TMO, TMO, TECH, TECH, SIAL, SIAL, PKI, PKI, MYGN, MYGN, LMNX, LMNX, LIFE, LIFE, ILMN, ILMN, GPRO, GPRO, GHDX, GHDX, FLDM, FLDM, CPHD, CPHD, BRKR, BRKR, BIO, BIO, ALR, ALR, WAT, WAT |
| theflyonthewall.com: | Leerink's life science tools and diagnostics analyst to hold a conference call | | Life Sciences Analyst Leonard, along with Chris Molloy, Vice President of IDBS, discuss the outlook for Electronic Laboratory Notebooks (ELNs), the impact of the America Invents Act and the opportunities in scientific software on an Analyst/Industry conference call. Relevant covered companies AFFX, ALR, BIO, BRKR, CPHD, FLDM, GHDX, GPRO, ILMN, LIFE, LMNX, MYGN, PKI, SIAL, TECH, TMO and WAT may be discussed on the Analyst/Industry conference call to be held on December 13 at 1 pm hosted by Leerink. :theflyonthewall.com |
|
|
News For AFFX;ALR;BIO;BRKR;CPHD;FLDM;GHDX;GPRO;ILMN;LIFE;LMNX;MYGN;PKI;SIAL;TECH;TMO;WAT From The Last 14 Days Check below for free stories on AFFX;ALR;BIO;BRKR;CPHD;FLDM;GHDX;GPRO;ILMN;LIFE;LMNX;MYGN;PKI;SIAL;TECH;TMO;WAT the last two weeks.
There are 49 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 23, 2012
|
| 07:03 EDT |  | BRKR |
| theflyonthewall.com: | Bruker awarded $25M contract from Russia's Rosatom | | Bruker announced a large-scale technology transfer contract for its Bruker HTS GmbH subsidiary to license and transfer know-how for second generation YBCO ceramic tape high temperature superconductors to a subsidiary of the Russian state atomic energy corporation, Rosatom. The total contract value exceeds $25M, and BEST revenue is expected in various increments and milestones over an approximately two-year period, with expected deliveries commencing in 2013. :theflyonthewall.com |
| | 07:02 EDT | | CPHD |
|
|
May 22, 2012
|
| 07:45 EDT |  | GHDX |
| theflyonthewall.com: | Genomic Health target raised to $43 from $33 at JMP Securities | | After conducting due diligence with oncology surgeons, JMP Securities believes that Genomic's DCIS test could potentially generate a large amount of revenue. The firm reiterates an Outperform rating. :theflyonthewall.com |
| | 07:35 EDT | | GPRO |
|
|
May 21, 2012
|
| 16:06 EDT | | MYGN |
| theflyonthewall.com: | Myriad Genetics and Intermountain Healthcare enter research agreement | | Intermountain Healthcare and Myriad Genetics (MYGN) announced they have signed a collaborative research agreement. The purpose of this agreement is to perform research and validation studies on transformative molecular diagnostic tests being developed by Myriad in an effort to improve the care and treatments for patients at Intermountain and around the world. This collaboration highlights the shared purpose of Myriad and Intermountain in improving outcomes and the quality of life for patients. The first project under this collaboration, PRO 008, is designed to further expand the utility of the Prolaris test by analyzing biopsy samples of 200 patients diagnosed with prostate cancer. This study will assess the ability of the Prolaris test to predict which men are at a heightened risk of biochemical recurrence and therefore should be given more aggressive therapy for their disease. The goal of this, and Myriad's other Prolaris studies underway in multiple centers in the United States and Europe, is to demonstrate the prognostic ability of the Prolaris test in assessing a patient's risk of biochemical recurrence of disease and death from disease. :theflyonthewall.com |
| | 11:23 EDT | | TMO |
| | 10:34 EDT |  | WAT |
| theflyonthewall.com: | On The Fly: Analyst Upgrade Summary | | Today's noteworthy upgrades include: Alpha Natural (ANR) upgraded to Buy from Hold at Brean Murray... American Eagle (AEO) upgraded to Buy from Hold at Brean Murray... Group 1 Automotive (GPI) upgraded to Buy from Neutral at Sterne Agee... LPL Investment (LPLA) upgraded to Neutral from Negative at Susquehanna... Mid-Con Energy (MCEP) upgraded to Outperform from Market Perform at Raymond James... Safeway (SWY) upgraded to Buy from Neutral at Citigroup... United Bankshares (UBSI) upgraded to Buy from Neutral at Janney Capital... Waters (WAT) upgraded to Buy from Neutral at Mizuho... Boeing (BA) upgraded to Buy from Hold at Argus. :theflyonthewall.com |
| | 07:38 EDT | | MYGN |
| | 07:30 EDT | | MYGN |
| | 07:25 EDT | | LIFE |
| theflyonthewall.com: | Life Technologies shares undervalued, says Oppenheimer | | After meeting with Life's management, Oppenheimer believes that investors' concerns that the company will abandon its share buyback plans are unwarranted. The firm reiterates a $58 target and Outperform rating on the stock. :theflyonthewall.com |
| | 05:34 EDT | | WAT |
|
|
May 18, 2012
|
| 10:31 EDT | | FLDM |
| theflyonthewall.com: | Fluidigm management to meet with Leerink | | Meetings to be held in Minneapolis on May 22, in Chicago on May 23 and in Dallas on May 24 hosted by Leerink. :theflyonthewall.com |
|
|
May 17, 2012
|
| 10:33 EDT |  | WAT, TMO, BRKR |
| theflyonthewall.com: | On The Fly: Analyst Initiation Summary | | Today's noteworthy initiations include: Agilent (A) initiated with an Outperform at Wells Fargo... Alphatec (ATEC) initiated with an Overweight at Piper Jaffray... ArthroCare (ARTC) initiated with an Overweight at Piper Jaffray... Bruker (BRKR) initiated with an Outperform at Wells Fargo... CareFusion (CFN) initiated with an Overweight at Piper Jaffray... Celadon Group (CGI) initiated with a Buy at Wunderlich... Crocs (CROX) initiated with a Neutral at SunTrust... Infoblox (BLOX) initiated with an Outperform at JMP Securities... Kirby (KEX) initiated with a Buy at Wunderlich... Knight Transportation (KNX) initiated with a Buy at Wunderlich... Micron (MU) initiated with a Neutral at Susquehanna... Rush Enterprises (RUSHA) initiated with a Buy at Wunderlich... SanDisk (SNDK) initiated with a Positive at Susquehanna... Swift Transportation (SWFT) initiated with a Buy at Wunderlich... Thermo Fisher (TMO) initiated with a Market Perform at Wells Fargo... Tyler Technologies (TYL) initiated with a Buy at Benchmark Co... Waters (WAT) initiated with an Outperform at Wells Fargo... Werner (WERN) initiated with a Buy at Wunderlich... US Airways (LCC) initiated with an Outperform at Raymond James. :theflyonthewall.com |
| | 09:20 EDT | | CPHD |
| | 07:32 EDT | | AFFX |
| | 07:27 EDT | | SIAL |
| theflyonthewall.com: | Sigma-Aldrich initiated with a Market Perform at Wells Fargo | | Price target range $75-$80. :theflyonthewall.com |
| | 06:45 EDT | | BRKR |
| | 06:44 EDT | | TMO |
| theflyonthewall.com: | Thermo Fisher initiated with a Market Perform at Wells Fargo | | Price target range $55-$60. :theflyonthewall.com |
| | 06:43 EDT | | WAT |
| theflyonthewall.com: | Waters initiated with an Outperform at Wells Fargo | | Price target range $98-$103. :theflyonthewall.com |
|
|
May 15, 2012
|
| 10:14 EDT |  | LIFE, TMO |
| | 10:14 EDT | | CPHD |
| theflyonthewall.com: | On The Fly: Analyst Upgrade Summary | | Today's noteworthy upgrades include: Akamai (AKAM) upgraded to Buy from Neutral at Janney Capital... Amazon.com (AMZN) upgraded to Outperform from Neutral at Credit Suisse... Amedisys (AMED) upgraded to Outperform from Neutral at RW Baird... Cepheid (CPHD) upgraded to Buy from Neutral at UBS... Dominion (D) upgraded to Buy from Hold at Jefferies... Flextronics (FLEX) upgraded to Buy from Neutral at BofA/Merrill... Gentiva Health (GTIV) upgraded to Neutral from Underperform at RW Baird... Jabil Circuit (JBL) upgraded to Buy from Neutral at BofA/Merrill... Juniper (JNPR) upgraded to Buy from Neutral at BofA/Merrill... KiOR (KIOR) upgraded to Buy from Neutral at Citigroup... MIPS Technologies (MIPS) upgraded to Buy from Hold at Benchmark Co... Silver Wheaton (SLW) upgraded to Outperform from Neutral at Macquarie... Southern Company (SO) upgraded to Buy from Hold at Jefferies. :theflyonthewall.com |
| | 07:30 EDT | | BIO |
| | 06:32 EDT | | CPHD |
| | 06:25 EDT | | TMO |
| theflyonthewall.com: | Thermo Fisher downgraded to Neutral from Buy at Mizuho | | Mizuho downgraded Life Technologies (LIFE) and Thermo Fisher (TMO) citing uncertainty surrounding academic spending. :theflyonthewall.com |
| | 06:25 EDT | | LIFE |
|
|
May 14, 2012
|
| 09:08 EDT | | GPRO |
| | 07:01 EDT | | BRKR |
|
|
May 11, 2012
|
| 22:06 EDT | | GHDX |
| | 16:15 EDT |  | ALR |
| theflyonthewall.com: | On The Fly: Closing Wrap | | Stocks on Wall Street were mixed, as the Nasdaq was just barely able to cling to a marginal gain for the session. Stock futures pointed to a sharply lower open following JPMorgan’s (JPM) announcement of a $2B trading loss. The futures moved off their lows prior to the open but the broader market opened in negative territory. The averages found a level where they began to build following the highest consumer confidence reading since January 2008. Each of the major indices made it to positive territory and then went into a slow drift lower, with only the Nasdaq avoiding a return to the red... ECONOMIC EVENTS: Domestically, the producer price index report showed that prices fell 0.2% in April, versus expectations for no change. The core reading, which strips out food and energy, rose 0.2%, which was in line with expectations. The University of Michigan Consumer Confidence reading was 77.8, stronger than the expected 76 reading and its highest level since January 2008. Internationally, data from China and India may signal a further weakening of the global recovery, as China reported its industrial production rose 9.3% from a year ago in April while India's industrial output fell 3.5% in March from the prior year... COMPANY NEWS: The surprising announcement from JPMorgan of a $2B trading loss at one of its divisions triggered calls for tougher bank regulation and a sell off in its shares. CEO Jamie Dimon admitted to “egregious” failures in its risk management and said the losses could deepen this quarter and beyond, sending its stock down more than 9%... MAJOR MOVERS: Among the notable gainers were Arena Pharmaceuticals (ARNA), up $2.70, or 73.77%, to $6.36, after an FDA panel backed the approval of its weight loss drug, lorcaserin, and Monster Worldwide (MWW), up $1.50, or 19.13%, to $9.33, after Reuters said the company has attracted takeover interest from LinkedIn (LNKD) and Silver Lake, but CNNMoney said sources close to LinkedIn denied that report. Noteworthy losers included Alere (ALR), down $3.28, or 14.71%, to $19.02, following its disclosure of a subpoena from the Department of Health and Human Services and the potential of broader recalls of certain products after an FDA inspection, and Chesapeake Energy (CHK), down $2.37, or 13.80%, to $14.81, after the company said it would need to delay its 10-Q filing and then made the filing shortly afterward, in which it said it may have to delay some of its asset sales... INDICES: The Dow lost 34.44, or 0.27%, to 12,820.60; the Nasdaq rose 0.18, or 0.01%, to 2,933.82; and the S&P 500 dropped 4.60, or 0.34%, to 1,353.39. :theflyonthewall.com |
| | 12:42 EDT | | ALR |
| | 12:00 EDT |  | ALR |
| | 10:24 EDT | | ALR |
| | 10:21 EDT | | ALR |
| | 10:00 EDT | | ALR |
| | 09:44 EDT | | ALR |
| theflyonthewall.com: | Alere gaps down sharply, support is at $18.77 | | :theflyonthewall.com |
| | 09:33 EDT | | WAT |
| | 09:19 EDT | | MYGN |
| | 09:00 EDT | | ALR |
| | 06:31 EDT | | ALR |
| | 06:11 EDT | | MYGN |
|
|
May 10, 2012
|
| 16:25 EDT | | ALR |
| | 16:25 EDT | | ALR |
| | 16:23 EDT | | ALR |
| | 16:22 EDT | | ALR |
| | 16:01 EDT |  | FLDM |
| | 16:01 EDT | | FLDM |
| theflyonthewall.com: | Fluidigm reports Q1 EPS (33c), consensus (22c) | | Reports Q1 revenue $10.95M, consensus $10.76M. :theflyonthewall.com |
|
|
May 9, 2012
|
| 10:29 EDT | | AFFX |
| theflyonthewall.com: | On The Fly: Analyst Upgrade Summary | | Today's noteworthy upgrades include: AIG (AIG) upgraded to Buy from Neutral at Goldman... Affymetrix (AFFX) upgraded to Equal Weight from Underweight at Morgan Stanley... Callon Petroleum (CPE) upgraded to Outperform from Neutral at RW Baird... Demand Media (DMD) upgraded to Buy from Neutral at Citigroup... Dow Chemical (DOW) upgraded to Overweight from Equal Weight at Morgan Stanley... EZCORP (EZPW) upgraded to Neutral from Underperform at Sterne Agee... Fossil (FOSL) upgraded to Buy from Hold at Benchmark Co... Inteliquent (IQNT) upgraded to Outperform from Neutral at RW Baird... Magellan Health (MGLN) upgraded to Buy from Neutral at BofA/Merrill... Scotts Miracle-Gro (SMG) upgraded to Market Perform from Underperform at BMO Capital... St. Jude Medical (STJ) upgraded to Overweight from Equal Weight at Morgan Stanley... Under Armour (UA) upgraded to Buy from Neutral at UBS... Veeco (VECO) upgraded to Overweight from Neutral at Piper Jaffray... Hershey (HSY) upgraded to Buy from Hold at Argus... U.S. Auto Parts (PRTS) upgraded to Buy from Neutral at Roth Capital. :theflyonthewall.com |
| | 07:10 EDT | | BRKR |
| theflyonthewall.com: | Bruker subsidiary awarded $5.2M in contracts for accelerator modules | | Bruker Energy & Supercon Technologies (BRKR)'s majority-owned subsidiary RI Research Instruments GmbH has been awarded a contract with the South Korea-based Pohang Accelerator Laboratory for the supply of a 500 MHz superconducting accelerator module, as well as the award of another contract with the Diamond Light Source in Great Britain for a similar 500 MHz superconducting accelerator module. The value of both contracts together is approximately $5.2M. :theflyonthewall.com |
| | 06:29 EDT | | AFFX |
| theflyonthewall.com: | Affymetrix upgraded to Equal Weight from Underweight at Morgan Stanley | | Morgan Stanley upgraded Affymetrix based on its eBioscience acquisition. :theflyonthewall.com |
|
|
|
|
|
Subscribe for More Information